MEDIDAT
ActiveFrom the official registers: KBO 40 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
MEDIDAT has been active since 1985 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €43,444 and a net result of €1,007. Equity has been stable since 2018 (±1.2% per year). Its solvency ranks better than 78% of 13,716 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Overview
Official details
KBO- Status
- Active since 18-11-1985 Normal situation
- Activity
- Wholesale of pharmaceutical and medical goods NACE 46460
- Establishment unit
- 2.028.295.140 2610 Antwerpen, since 01-12-1985
- Financial year end
- 31 December
- Peppol
- Reachable since 30-11-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.8%
- Gross margin
- €5,485
- Turnover
- ≈ €54,000
- estimated
- Profit
- €1,007
- Equity
- €43,444
- ▼ 34.3%
- Total assets
- €57,897
- ▼ 31.6%
Score breakdownraises riskLast filed accounts filed 74 days late; 2 of the last 3 accounts lateLiquidity: current ratio 4.01lowers riskFounded in 1985Figures for financial year 2025 (filed on 20-10-2026)Show the evidence
Checked score
About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 90% of them on solvency, 83% on liquidity, 55% on profitability and 13% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 10 days after the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Comparable companies
These companies have the same main activity as MEDIDAT: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €20,400 and €128,000, founded between 1968 and 1999.
| Company | Total assets | Gross margin |
|---|---|---|
| MEDIDAT Antwerpen | €57,897 | €5,485 |
| KINERGY Assenede | €30,483 | €8,054 |
| GYNTECH Antwerpen | €20,358 | €5,554 |
| CAPRICORN COMMUNICATION Elsene | €27,186 | €7,672 |
| SCIENCE ET MEDECINE Waterloo | €127,922 | €2,751 |
| REYNAERT RESEARCH Gent | €46,825 | €13,058 |
| Laboratoire du Docteur Vétérinaire Domicent Mons | €37,195 | €2,265 |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 13-10-2026
- Annual accounts 2024filed on 24-09-2025
- Annual accounts 2023filed on 30-08-2024
- Annual accounts 2022filed on 01-09-2023
Acts in the Belgian Official Gazette
All publications in the Belgian Official GazetteArticles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about MEDIDAT
- What is the company number of MEDIDAT?
- The company number of MEDIDAT is 0428.034.076. The VAT number is the same number with BE in front: BE 0428.034.076.
- Where is MEDIDAT based?
- The registered office is at De Bruynlaan 72, 2610 Antwerpen.Company details
- What does MEDIDAT do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of MEDIDAT?
- The legal form of MEDIDAT is Private limited company (pre-2019) (BVBA).
- When was MEDIDAT founded?
- MEDIDAT was founded on 18-11-1985.
- Is MEDIDAT still active?
- Yes, MEDIDAT is an active enterprise in the KBO register.
- What is the turnover of MEDIDAT?
- The turnover in financial year 2025 is ≈ €54,000. This figure is estimated from the gross margin of €5,485 and 41 comparable companies (NACE 464). It probably lies between €31,000 and €220,000. It is a rough estimate.Financials
- Is MEDIDAT profitable?
- In financial year 2025, MEDIDAT made a profit of €1,007.
- Where can I find the annual accounts of MEDIDAT?
- MEDIDAT filed 40 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of MEDIDAT due?
- MEDIDAT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.